# Oat Beta Glucan Cholesterol Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/oat-beta-glucan-cholesterol-meta-analysis-evidence-review
Category: evidence-review
Summary: Oat Beta Glucan Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass a
Last reviewed: 2026-06-04
Reviewed by: Migaku Evidence Review
# Oat Beta Glucan Cholesterol Meta-analysis: What the Evidence Says

## Quick Answer

Oat Beta Glucan Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Cow’s milk compared to oat drink and its implications for lipid profile– a pilot randomized controlled trial | randomized trial | 2 | 2026-03-18 | 10.1186/s12937-026-01314-w |
| Combined Oat β-Glucan and Soy Protein Isolate Reprogram Gut Microbiota and Improve Metabolic Dysfunction in Diet-Induced Obesity. | research article | 4 | 2026-05-15 | 10.3390/nu18101571 |

## What The Sources Report

- Cow's milk is nutrient-dense and, in Norway, national dietary guidelines recommend three daily servings of dairy products including low-fat milk to support adequate calcium and iodine intake. [Rosendahl-Riise Hanne (2026); evidence level 2]
- Current dietary guidelines, including those outlined in the Nordic Nutrition Recommendations (NNR2023), advocate for reduced intake of saturated fat. [Rosendahl-Riise Hanne (2026); evidence level 2]
- Functional prediction analysis specifically linked this microbial shift to the modulation of Akkermansia -associated metabolic pathways, which subsequently facilitated the activation of host metabolic networks to combat lipid deposition and systemic metabolic stress. [Guo Z (2026); evidence level 4]
- Background/objectives Although plant-derived dietary fiber and protein are favorable factors for improving host metabolic disorders, it remains unclear whether these two macronutrients exhibit synergistic health benefits. [Guo Z (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For oat beta glucan cholesterol meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Rosendahl-Riise Hanne (2026). Cow’s milk compared to oat drink and its implications for lipid profile– a pilot randomized controlled trial. DOI: 10.1186/s12937-026-01314-w. PMCID: PMC13112611. PMID: 41851782. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13112611/
- Guo Z (2026). Combined Oat β-Glucan and Soy Protein Isolate Reprogram Gut Microbiota and Improve Metabolic Dysfunction in Diet-Induced Obesity.. DOI: 10.3390/nu18101571. PMCID: PMC13209952. PMID: 42197031. https://pmc.ncbi.nlm.nih.gov/articles/PMC13209952/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.